A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia
Nadine E. Struckman(Leiden University Medical Center), Marieke Griffioen(Leiden University Medical Center), Arnoud H. de Ru(Leiden University Medical Center), Rob C. M. de Jong(Leiden University Medical Center), Dennis F.G. Remst(Leiden University Medical Center), Dyantha I. van der Lee(Leiden University Medical Center), Fumihiko Ishikawa(RIKEN Center for Integrative Medical Sciences), Peter J.M. Valk(Erasmus MC Cancer Institute), Sophie-Anne I. Smith(Leiden University Medical Center), Mirjam H.M. Heemskerk(Leiden University Medical Center), Georgia Koutsoumpli(Leiden University Medical Center), JH Falkenburg(Leiden University), Renate S. Hagedoorn(Leiden University Medical Center), M. Willy Honders(Leiden University Medical Center), Tamar Tak(Leiden University Medical Center), Masashi Matsuda(RIKEN Center for Integrative Medical Sciences), Peter A. van Veelen(Leiden University Medical Center)
Cited by 3
Related Papers
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k